Investors in Tesla (NASDAQ: TSLA) have arguably faced as much adversity in 2025 as they have at any point in the company’s young history. Right now, they are dealing with sales and profits spiraling lower, consumer backlash to Elon Musk’s political ambitions, and the State of California trying to suspend Tesla’s dealer license for 30 days, among other developments.
But there’s maybe an even bigger problem brewing, and one that will come with serious financial impact for the electric vehicle (EV) maker.
One big problem brewing for Tesla investors involves the company’s sale of regulatory credits. These sales have always been a part of the EV maker’s story, and for years, the company generated billions of dollars selling regulatory credits to its rivals.